主旨：國科會與法國國家癌症研究院共同徵求2027年雙邊合作研究計畫(3-4年期)，第一階段徵件由INCa受理至2025年11月3日截止。

說明:
一、依據國科會與INCa簽署之合作備忘錄,本會補助我國研究人員參與法方PLBIO方案,合作領域為癌症相關(得含認知科學)之原創知識或前瞻技術研究;惟不含轉譯學研究、臨床實驗、流行病與公共衛生研究等三類主題。
二、旨揭計畫暫定執行日期自2027年1月1日起,計畫徵求分「意向書」及「完整計畫書」兩階段申請作業,第一階段由法方計畫主持人偕同臺方計畫主持人至INCa線上申辦系統提交意向書。經INCa初審後,本會將邀請通過第一階段意向書審查之臺方計畫主持人,向本會研提第二階段完整計畫書;法方計畫主持人則向INCa研提第二階段完整計畫書,相關作業規定依INCa公告為準。
三、INCa徵件公告網頁:https://www.cancer.fr/professionnels-de-la-recherche/appels-a-projets-et-a-candidatures/nos-appels-a-projets/plbio2026)。
Subject: NSTC and the French National Cancer Institute are jointly soliciting proposals for bilateral collaborative research projects (3-4 years) for 2027. The first phase of applications will be accepted by INCa until November 3, 2025.

Explanation:
1. Pursuant to the Memorandum of Understanding signed between NSTC and INCa, this association will subsidize Taiwanese researchers to participate in the French PLBIO program. The collaborative areas are original knowledge or cutting-edge technological research related to cancer (which may include cognitive science), but translational research, clinical trials, and epidemiology and public health research are excluded.
2. The tentative implementation date of the proposed program is January 1, 2027. The application process consists of two phases: a "Letter of Intent" and a "Full Proposal." In the first phase, the French project leader and the Taiwanese project leader will submit a letter of intent through the INCa online application system. After initial review by INCa, the Association will invite Taiwanese project leaders who have passed the first-stage EOI review to submit a full Phase II proposal to the Association. French project leaders will submit a full Phase II proposal to INCa. The relevant procedures will be subject to INCa announcements.
3. INCa Call for Applications Announcement: https://www.cancer.fr/professionnels-de-la-recherche/appels-a-projets-et-a-candidatures/nos-appels-a-projets/plbio2026.